Trial Profile
Clinical Trials Insight: 700008785
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 24 Nov 2005
Price :
$35
*
At a glance
- Drugs Mapatumumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- 24 Nov 2005 New trial record.